American Bio Medica Corporation develops, manufactures and sells immunoassay tests, primarily for the immediate, point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The Company's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. In addition to the manufacture and sale of DOA POCT products, the Company provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. Its Rapid Drug Screen (RDS) is a POCT product that detects the presence or absence of 2 to 10 DOA simultaneously in a single urine specimen. The Rapid ONE product line consists of single drug tests, each of which tests for the presence or absence of a single drug of abuse in a urine specimen. The RDS InCup is a POCT product that detects the presence or absence of 1 to 12 DOA in a single urine specimen. The POCT products for oral fluid-based DOA testing include OralStat.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:ABMC
- CUSIP: N/A
- Web: www.abmc.com
- Market Cap: $2.93 million
- Outstanding Shares: 29,297,000
- 50 Day Moving Avg: $0.10
- 200 Day Moving Avg: $0.11
- 52 Week Range: $0.05 - $0.17
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $5.45 million
- Price / Sales: 0.54
- Book Value: $0.03 per share
- Price / Book: 3.33
- EBIDTA: ($152,999.00)
- Net Margins: -5.55%
- Return on Equity: -29.00%
- Return on Assets: -8.80%
- Debt-to-Equity Ratio: 0.78%
- Current Ratio: 1.38%
- Quick Ratio: 0.49%
- Average Volume: 8,484 shs.
- Beta: 0.69
- Short Ratio: 0.09
Frequently Asked Questions for American Bio Medica Corp. (OTCMKTS:ABMC)
What is American Bio Medica Corp.'s stock symbol?
American Bio Medica Corp. trades on the OTCMKTS under the ticker symbol "ABMC."
Who are some of American Bio Medica Corp.'s key competitors?
Some companies that are related to American Bio Medica Corp. include Strata Skin Sciences (SSKN), Rosetta Genomics (ROSG), NeuroMetrix (NURO), Critical Outcome T (COTQF), Windtree Therapeutics (WINT), Affymax (AFFY), Adeptus Health (ADPT), Bayer AG (BAYRY), DNIB Unwind (BIND), Echo Therapeutics (ECTE), ELEKTA (EKTAY), Epirus Biopharmaceuticals (EPRS), Essilor International SA (ESLOY), Fresenius SE (FSNUY), Luxottica Group SpA (LUX), Mast Therapeutics (MSTX), Parnell Pharmaceuticals Holdings Ltd (PARN) and Secure Point Technologies (IMSC).
Who are American Bio Medica Corp.'s key executives?
American Bio Medica Corp.'s management team includes the folowing people:
- Melissa A. Waterhouse, Chief Executive Officer, Principal Accounting and Financial Officer
- Jean Neff, Corporate Secretary, Independent Director
- Chaim Davis, Director
- Diane J Generous, Director
How do I buy American Bio Medica Corp. stock?
Shares of American Bio Medica Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is American Bio Medica Corp.'s stock price today?
MarketBeat Community Rating for American Bio Medica Corp. (OTCMKTS ABMC)MarketBeat's community ratings are surveys of what our community members think about American Bio Medica Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of American Bio Medica Corp. stock can currently be purchased for approximately $0.10.
Consensus Ratings for American Bio Medica Corp. (OTCMKTS:ABMC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for American Bio Medica Corp. (OTCMKTS:ABMC)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for American Bio Medica Corp. (OTCMKTS:ABMC)Earnings History by Quarter for American Bio Medica Corp. (OTCMKTS ABMC)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for American Bio Medica Corp. (OTCMKTS:ABMC)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for American Bio Medica Corp. (OTCMKTS:ABMC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for American Bio Medica Corp. (OTCMKTS:ABMC)
Insider Ownership Percentage: 3.32%Insider Trades by Quarter for American Bio Medica Corp. (OTCMKTS:ABMC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/31/2014||Mp Biomedicals Llc||Major Shareholder||Buy||23,000||$0.13||$2,990.00|| |
Headline Trends for American Bio Medica Corp. (OTCMKTS:ABMC)
Latest Headlines for American Bio Medica Corp. (OTCMKTS:ABMC)
American Bio Medica Corp. (ABMC) Chart for Friday, July, 28, 2017